Home
>
US Stocks
>
Verrica Pharmaceuticals Inc
Verrica Pharmaceuticals Inc
VRCA

Verrica Pharmaceuticals Inc (VRCA)

$12.944.27%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$12.91
Today Low/High$12.85 / $13.12
52 Week Low/High$7.05 / $18.42
Market Cap$341.46M

Company Details

Verrica is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. Verrica's late-stage product candidate, VP-102, is in development to treat molluscum contagiosum (molluscum), common warts and external genital warts, three of the largest unmet needs in medical dermatology. Verrica is also developing VP-103, its second cantharidin-based product candidate, for the treatment of plantar warts. The Company has also entered a worldwide license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatologic oncology conditions.
OrganisationVerrica Pharmaceuticals Inc
HeadquatersWest Chester, Pennsylvania, US
Employees29
IndustryHealth Technology
CEOTed White

Discover more

Frequently Asked Questions

What is Verrica Pharmaceuticals Inc (VRCA) share price today?

Can Indians buy Verrica Pharmaceuticals Inc (VRCA) shares?

How can I buy Verrica Pharmaceuticals Inc (VRCA) shares from India?

Can Fractional shares of Verrica Pharmaceuticals Inc (VRCA) be purchased?

What are the documents required to start investing in Verrica Pharmaceuticals Inc (VRCA) stocks?

We are a SEBI registered investement advisor